Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FWONA | ARXS |
|---|---|---|
| Price | $83.42 | $48.26 |
| Change today | ▼ 1.43% | ▼ 2.29% |
| Market cap | $20.91B | $20.79B |
| Return, 3 months | -7.8% | +3.7% |
| Return, year to date | -6.7% | – |
| Return, 1 year | -11.0% | – |
| P/E (TTM) | 124.5 | 157.2 |
| P/B | 2.7 | 4.7 |
| P/E percentile vs own 5y | 97th | 19th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -30.4% | +25.0% |
| Net profit growth (YoY) | -96.1% | +83.2% |
| Gross margin | 35.5% | 50.3% |
| Operating margin | 12.2% | 6.1% |
| Net margin | 9.4% | 1.8% |
| Return on equity | 5.3% | 0.7% |
| Analyst target vs. price | +40.3% | +26.8% |
| Analyst buy share | 100% | 86% |
| RSI (14) | 36 | 43 |
| 30-day volatility | 22.1% | 34.1% |
| Max drawdown, 1 year | -25.0% | -19.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
